Neuropsychopharmacology. 2012 Jun 13. doi: 10.1038 / npp.2012.97.
Radke AK, Gewirtz JC.
Source
Mmemme gụsịrị akwụkwọ na Neuroscience, Minneapolis, MN, USA.
nkịtị
Ọtụtụ usoro nke akaebe na-egosi na mgbaàmà mmetụta uche na-adịghị mma nke mwepu na-agụnye ọrụ belata na sistemụ mesolimbic dopamine. Ọmụmụ ihe a nyochara ntinye aka nke dopaminergic sign na owuwu ala nke mpaghara ventral tegmental akụkụ iji wezuga na ngosipụta morphine dị nnukwu, nke a tụrụ dị ka ike nke mmalite acoustic. Nlekọta sistemu nke dopamine receptor agonist apomorphine ma ọ bụ mmanya nke D1-like receptor agonist SKF82958 na D2-like receptor agonist quinpirole attenuated potentiated startle n'oge mbido morphine. A na - emeghachi mmetụta a site na infomorphine infusion n'ime akwara nucleus. Na mmechi, a gosipụtara injection apomorphine iji belata ite ọkụ na - amalite n'oge nicotine ma nwekwaa ọnọdụ na-egbochi iwepu morphine. Nsonaazụ ndị a na-atụ aro na ịgbatị oge nke sistemụ mpaghara nsogbu nke sistemụ na-akpalite ngosipụta nke ụjọ na mgbagha n'oge iweghachite n'ọtụtụ ọmụmụ nke ọgwụ ọjọọ.
;